David Hinds, PhD
Principal Scientist, Statistical Genetics
David joined 23andMe in 2009. He leads the 23andMe statistical genetics group and works on understanding the role of genetics in disease and complex traits. Prior to 23andMe, he spent nine years at Perlegen Sciences as lead analyst for the company’s genome-wide polymorphism discovery projects and contributed to the International HapMap Project. David earned his PhD in Structural Biology from Stanford University having received a Howard Hughes Medical Institute predoctoral fellowship.
Joanna L. Mountain, PhD
Senior Director of Research
Joanna joined 23andMe in 2007 and is responsible for overseeing research projects, ensuring the protection of research participants, and developing ancestry product offerings. Prior to joining 23andMe, Joanna earned a PhD in Genetics from Stanford University and served on the faculties of the Anthropological Sciences and Genetics Departments at Stanford. She has been awarded multiple grants from the National Science Foundation and the National Institutes of Health and has authored or co-authored over 50 papers in the field of human genetics. Joanna spent two years in Kenya as a Peace Corps volunteer and continues to be particularly interested in the genetic diversity of Africa.
Geoff Benton, PhD
Director, Health R&D
Geoff joined 23andMe in 2010 and works with a small team focused on identifying, researching, and developing new health products and features. Previously, he was a venture capital intern at Burrill and Company where he performed due diligence on prospective investments as well as sourced potential new investment deals. Geoff earned his PhD in Cell Biology from the University of California, San Francisco.
Vladimir Vacic, PhD
Senior Scientist, Computational Biology
Vladimir joined 23andMe in 2015 and manages the Computational Biology group within the Research team. He leads the analysis of research sequencing data and works closely with the Therapeutics team on computational analysis of candidate drug targets. Prior to joining 23andMe, he was one of the founding scientists at the New York Genome Center, where he was leading a cancer genome analysis and computational biology group. Vladimir earned his Ph.D. in Computer Science from the University of California, Riverside and trained as a postdoctoral fellow in computational genetics at Cold Spring Harbor Laboratory and Columbia University.
Carrie Northover, PhD
Scientist, Project Manager
Carrie joined 23andMe in 2013 and is responsible for managing genomic services partnerships. Carrie serves as the primary point of contact for internal and external project stakeholders as she guides cross-functional collaborations through the project lifecycle. Prior to 23andMe, Carrie was an IP licensing intern at University of California, San Francisco Office of Technology Transfer and a Research Contracts intern at Genentech. She completed her graduate studies at Stanford University where she studied cell fate and polarity.
Sarah Elson, PhD
Senior Scientist, Program Management
Sarah joined 23andMe in 2013 and is primarily responsible for managing research policy and health research and development. Previously, Sarah was the research program manager for the Athena Breast Health Network, a University of California initiative in breast cancer prevention and care. She also worked as a science writer and patent agent at Exelixis, Inc. Sarah earned her PhD in biomedical sciences from the University of California, San Francisco, where she was a National Science Foundation graduate research fellow.
Michelle Agee, MS
Michelle joined 23andMe in 2014. Her primary responsibilities are to ensure the protection of the company’s research participants and to make sure 23andMe studies comply with all laws and regulations for each country where research is conducted. Previously, she had a similar role in research ethics and compliance at the Institute for Health Metrics and Evaluation (IHME), an independent global health research center at the University of Washington. Michelle received a Master’s of Science degree in International Healthcare Management, Economics, and Policy from Bocconi University in Milan, Italy.
Anna Faaborg, MS
Research and Disease Community Manager
Anna joined 23andMe in 2013 and oversees research communities. These studies actively recruit participants with specific conditions, such as lupus, with the goals of uncovering the genetic factors contributing to disease risk, severity, and response to treatments. Previously, she was a project manager at Genentech, where she managed execution of biomarker plans for oncology clinical trials. Anna received a Master’s degree in Genetics and Development from Columbia University, studying the genetics of human skin and hair disorders.